“pembrolizumab” Archives

in
Entry Author Date Location
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies 12/19/19 New York
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
Gilliland to Step Down as Head of Fred Hutch in 2020 09/17/19 Seattle
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck 07/24/19 New York
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Merck Bags Tilos, Adding an Immunotherapy Booster to Its Arsenal 06/10/19 Boston
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects? 05/29/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Bayer Snaps Up Rights to Two Cancer Drugs from Lilly’s $8B Loxo Deal 02/15/19 Indiana
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More 02/15/19 National
Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter 01/16/19 National
In a Huge Biopharma Shakeup, Bristol-Myers to Buy Celgene For $74B 01/03/19 National
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Genetic Medicine: FDA OKs 2nd Cancer Drug That Targets DNA, Not Tissues 11/26/18 National
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
A Year Early, Merck Touts Good Kidney Cancer News to Push Rival BMS 10/18/18 New York
Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up 10/12/18 New York
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
Page 1 of 5 next page »